ono 3307 has been researched along with gabexate in 3 studies
Studies (ono 3307) | Trials (ono 3307) | Recent Studies (post-2010) (ono 3307) | Studies (gabexate) | Trials (gabexate) | Recent Studies (post-2010) (gabexate) |
---|---|---|---|---|---|
12 | 0 | 1 | 743 | 53 | 106 |
Protein | Taxonomy | ono 3307 (IC50) | gabexate (IC50) |
---|---|---|---|
Solute carrier family 22 member 2 | Homo sapiens (human) | 0.9 | |
Coagulation factor X | Homo sapiens (human) | 4.61 | |
Plasminogen | Homo sapiens (human) | 0.431 | |
Urokinase-type plasminogen activator | Homo sapiens (human) | 0.431 | |
Serine protease hepsin | Homo sapiens (human) | 0.383 | |
Multidrug and toxin extrusion protein 1 | Homo sapiens (human) | 0.5 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Pilgram, O; Steinmetzer, T; Wenzel, BM; Wiedemeyer, SJA | 1 |
Hirano, T; Manabe, T; Tobe, T | 1 |
Futagami, M; Imaki, K; Kawasaki, A; Matsuoka, S; Ohno, H; Okegawa, T | 1 |
3 other study(ies) available for ono 3307 and gabexate
Article | Year |
---|---|
Fibrinolysis Inhibitors: Potential Drugs for the Treatment and Prevention of Bleeding.
Topics: Animals; Antifibrinolytic Agents; Catalytic Domain; Crystallography, X-Ray; Fibrinolysin; Fibrinolysis; Hemorrhage; Humans; Ligands; Molecular Structure; Plasminogen; Protein Binding; Protein Domains | 2020 |
Protection by a new synthetic protease inhibitor, ONO3307, of the rat exocrine pancreas during acute edematous pancreatitis induced by a supramaximal dose of caerulein in comparison with FOY007.
Topics: Acute Disease; Amylases; Animals; Body Water; Cathepsin B; Ceruletide; Edema; Gabexate; Guanidines; L-Lactate Dehydrogenase; Lysosomes; Male; Pancreas; Pancreatitis; Rats; Rats, Inbred Strains; Serine Proteinase Inhibitors | 1992 |
Inhibitory effects of ONO-3307 on various proteases and tissue thromboplastin in vitro and on experimental thrombosis in vivo.
Topics: Animals; Benzamidines; Dialysis; Endotoxins; Fibrinolytic Agents; Gabexate; Guanidines; Humans; In Vitro Techniques; Indicators and Reagents; Kinetics; Leukocytes; Male; N-Formylmethionine Leucyl-Phenylalanine; Pancreatic Elastase; Rats; Rats, Inbred Strains; Serine Proteinase Inhibitors; Thromboplastin | 1989 |